Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study. (EXPEDIENT)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Nieuwegein, Netherlands
- St. Antonius Hospital
-
Utrecht, Netherlands
- Diakonessenhuis
-
Woerden, Netherlands
- Zuwe Hofpoort Ziekenhuis Woerden, Netherlands
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Histologically confirmed diagnosis of prostate cancer on biopsy
- Locally advanced or metastasised prostate cancer in need of hormonal treatment.
- On LHRH analogue treatment for a minimum of 5 months (at inclusion)
- Having a female partner
- Patients and their partner are able to fill out questionnaires, attend group sessions and give consent
Exclusion Criteria:
- Serious psychiatric difficulties
- Life expectancy < 12 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control group
|
|
|
EXPERIMENTAL: Intervention group
|
Attendance at 7 group sessions, consisting of 5-6 couples, preceded by an intake consultation.
Total intervention time: 16 weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sufficient interest in participation
Time Frame: Up to the end of 16 weeks of the intervention period
|
Determined by achievement of all of the following:
|
Up to the end of 16 weeks of the intervention period
|
|
Preliminary improvement in well-being
Time Frame: After the intervention period of 16 weeks
|
Improved - Group 1 improve more than group 2 on at least one of the outcome measures (includes HADS, EORTC QLQ-C30 or Maudsley Marital Questionnaire). Worsened - Group 1 should not worsen more than group 2 on any of the outcome measures. |
After the intervention period of 16 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in quality of life questionnaire QLQ-C30 scores
Time Frame: Baseline (T0), after the intervention period of 16 weeks (T1) and 1 year (T2)
|
Baseline (T0), after the intervention period of 16 weeks (T1) and 1 year (T2)
|
|
Change in quality of life questionnaire QLQ-PR25 scores
Time Frame: Baseline(T0), after the intervention period of 16 weeks (T1) and 1 year (T2)
|
Baseline(T0), after the intervention period of 16 weeks (T1) and 1 year (T2)
|
|
Difference in relationship satisfaction (Maudsley Marital Questionnaire)
Time Frame: Baseline (T0), after the intervention period of 16 weeks (T1) and 1 year (T2)
|
Baseline (T0), after the intervention period of 16 weeks (T1) and 1 year (T2)
|
|
Difference between level of depression and anxiety (HADS)
Time Frame: Baseline (T0) and 1 year (T2)
|
Baseline (T0) and 1 year (T2)
|
|
Change in Hospital Anxiety and Depression Scale (HADS) scores
Time Frame: Baseline (T0), after the intervention period of 16 weeks (T1)
|
Baseline (T0), after the intervention period of 16 weeks (T1)
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- A-95-52014-192
- 2011-004819-24 (EUDRACT_NUMBER)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.